These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 31422541)
1. The Expression Analysis of Intestinal Cancer Stem Cell Marker Lgr5 in Colorectal Cancer Patients and the Correlation with Histopathological Markers. Salehzadeh S; Hasanzad M; Kadijani AA; Akbari A J Gastrointest Cancer; 2020 Jun; 51(2):591-599. PubMed ID: 31422541 [TBL] [Abstract][Full Text] [Related]
2. A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer? Mirzaei A; Tavoosidana G; Rad AA; Rezaei F; Tavakoli-Yaraki M; Kadijani AA; Khalili E; Madjd Z Tumour Biol; 2016 Feb; 37(2):2405-14. PubMed ID: 26383518 [TBL] [Abstract][Full Text] [Related]
3. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance. He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer. Gzil A; Zarębska I; Jaworski D; Antosik P; Durślewicz J; Maciejewska J; Domanowska E; Skoczylas-Makowska N; Ahmadi N; Grzanka D; Szylberg Ł J Cancer Res Clin Oncol; 2020 Oct; 146(10):2547-2557. PubMed ID: 32671503 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients. Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749 [TBL] [Abstract][Full Text] [Related]
6. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer. Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells. Kemper K; Prasetyanti PR; De Lau W; Rodermond H; Clevers H; Medema JP Stem Cells; 2012 Nov; 30(11):2378-86. PubMed ID: 22969042 [TBL] [Abstract][Full Text] [Related]
8. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis. Kang XL; He LR; Chen YL; Wang SB World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA Expression Levels and Histopathological Features of Colorectal Cancer. Emami SS; Akbari A; Zare AA; Agah S; Masoodi M; Talebi A; Minaeian S; Fattahi A; Moghadamnia F J Gastrointest Cancer; 2019 Jun; 50(2):276-284. PubMed ID: 29404790 [TBL] [Abstract][Full Text] [Related]
10. LGR5 overexpression confers poor relapse-free survival in breast cancer patients. Hou MF; Chen PM; Chu PY BMC Cancer; 2018 Feb; 18(1):219. PubMed ID: 29471794 [TBL] [Abstract][Full Text] [Related]
11. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer. Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894 [TBL] [Abstract][Full Text] [Related]
12. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer. Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827 [TBL] [Abstract][Full Text] [Related]
13. Significance of Lgr5(+ve) cancer stem cells in the colon and rectum. Takahashi H; Ishii H; Nishida N; Takemasa I; Mizushima T; Ikeda M; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M Ann Surg Oncol; 2011 Apr; 18(4):1166-74. PubMed ID: 21125339 [TBL] [Abstract][Full Text] [Related]
14. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer. Stanisavljević L; Myklebust MP; Leh S; Dahl O Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662 [TBL] [Abstract][Full Text] [Related]
15. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1. Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430 [TBL] [Abstract][Full Text] [Related]
16. A Study on the Mechanism of Low-Expressed Cancer Stem Cell Marker Lgr5 in Inhibition of the Proliferation and Invasion of Colorectal Carcinoma. Jia H; Xiang L; Wang Z; Zhou Q Cell Biochem Biophys; 2015 Nov; 73(2):393-397. PubMed ID: 27352328 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis. Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050 [TBL] [Abstract][Full Text] [Related]
18. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival. Wu XS; Xi HQ; Chen L World J Surg Oncol; 2012 Nov; 10():244. PubMed ID: 23153436 [TBL] [Abstract][Full Text] [Related]
19. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis]. Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346 [No Abstract] [Full Text] [Related]
20. Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer. Su S; Hong F; Liang Y; Zhou J; Liang Y; Chen K; Wang X; Wang Z; Wang Z; Chang C; Han W; Gong W; Qin H; Jiang B; Xiong H; Peng L PLoS One; 2015; 10(11):e0143513. PubMed ID: 26599100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]